InvestorsHub Logo

Darius Demian

02/18/17 9:46 AM

#51745 RE: Arnie4 #51744

Canopy took over Mettrum for a reason. As per the news releases and conference call Mettrum is now under Canopy's full control. If you bought in the $2's and held through all previous noise I would suggest you trust your own instincts and DD over the Motley Fool. For what it's worth I'm still holding nearly 1/2 million and feeling more confident than ever. In the early days I was constantly refreshing the stock quotes on my phone. Now I usually only check in a couple times a day. With rec, research, and Germany around the corner, things have never looked brighter. What started as a speculative investment has essentially become my only real investment over the past few years. Have a great weekend.

OnlyGoLong

02/18/17 9:47 AM

#51746 RE: Arnie4 #51744

If you had listened to motley fool on the way up then you never would be in the situation you are in right now, up over 200%.

The reality is tweed/bedrocan do not have issues and this whole issue is what allowed canopy to land this deal with such a small premium. Mettrum still has patients, products, hemp line & room to expand.

Canopy hasn't begun to scratch the surface of its quarterly revenues, with Germany opening up and getting very medical licensed as well. If the share price is lower in 2 years than what it is today I would be absolutely stunned.